|
Volumn 136, Issue 12, 2000, Pages 1461-1469
|
Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: Results of phase 1 and 2 trials
a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALITRETINOIN;
CD4 ANTIGEN;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT;
ARTICLE;
CANCER GROWTH;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
GEL;
HUMAN;
KAPOSI SARCOMA;
LYMPHOCYTE COUNT;
MAJOR CLINICAL STUDY;
MALE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SKIN MANIFESTATION;
T LYMPHOCYTE SUBPOPULATION;
TREATMENT OUTCOME;
ADMINISTRATION, CUTANEOUS;
ADULT;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTINEOPLASTIC AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
GELS;
HUMANS;
MALE;
MIDDLE AGED;
SARCOMA, KAPOSI;
SKIN NEOPLASMS;
TREATMENT OUTCOME;
TRETINOIN;
UNITED STATES;
|
EID: 0034528018
PISSN: 0003987X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (64)
|
References (35)
|